<DOC>
	<DOCNO>NCT01792388</DOCNO>
	<brief_summary>Increased Intestinal Permeability detectable clinically active Crohn 's disease , stable Crohn 's disease predictive clinical relapse . Maintenance epithelial barrier integrity therefore essential intestinal homeostasis . Vitamin D may critical role improve barrier function .</brief_summary>
	<brief_title>Vitd Barrier Function IBD</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>All patient must fulfill clinical criterion diagnosis CD define LennardJones et al . ( 1976 ) All patient must clinical remission least 1 month study entry define Crohn 's Disease Activity Index ( CDAI ) &lt; 150 1865 year Patients stable drug therapy least 1 month preenrolment Sufficient English language ability carry study requirement Symptomatic CD study entry include CDAI &gt; 150 Pregnancy Previous extensive small bowel resection ( le 200 cm viable small bowel loss 50 % small intestine ) Presence ileostomy colostomy Known hypersensitivity vitamin D Hypercalcaemia ( correct serum calcium &gt; 2.66 mmol/L ) Those currently use supplemental vitamin D &gt; 800 IU/D Diagnosis follow : active tuberculosis , sarcoidosis , hyperparathyroidism , renal failure , pseudohyperparathyroidism , malignancy , active , lymphoma , short bowel syndrome Antibiotic use 4 week prior enrolment Current use bisphosphonates Renal Impairment , Diabetes Mellitus Patients participate concurrent RCT Alcohol dependency</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Crohn 's Disease</keyword>
	<keyword>Vitamin D</keyword>
	<keyword>Intestinal Permeability</keyword>
	<keyword>Tara Raftery</keyword>
</DOC>